Cite
HARVARD Citation
Gudi, G. et al. (n.d.). 96PPreliminary pharmacokinetic results from a phase I study of GBR 1302 in patients with HER2 positive cancers. Annals of oncology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gudi, G. et al. (n.d.). 96PPreliminary pharmacokinetic results from a phase I study of GBR 1302 in patients with HER2 positive cancers. Annals of oncology. p. . [Online].